Literature DB >> 18392953

Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations.

Mahmoud R Hussein1, Nehal A Fathi, Azza M Ezz El-Din, Hewayda I Hassan, Fatemah Abdullah, Eman Al-Hakeem, Eman Abo Backer.   

Abstract

Rheumatoid arthritis is a multisystem disease with underlying immune mechanisms. Osteoarthritis is a debilitating, progressive disease of diarthrodial joints associated with the aging process. Although much is known about the pathogenesis of rheumatoid arthritis and osteoarthritis, our understanding of some immunologic changes remains incomplete. This study tries to examine the numeric changes in the T cell subsets and the alterations in the levels of some cytokines and adhesion molecules in these lesions. To accomplish this goal, peripheral blood and synovial fluid samples were obtained from 24 patients with rheumatoid arthritis, 15 patients with osteoarthritis and six healthy controls. The counts of CD4 (+) and CD8 (+) T lymphocytes were examined using flow cytometry. The levels of some cytokines (TNF-alpha, IL1-beta, IL-10, and IL-17) and a soluble intercellular adhesion molecule-1 (sICAM-1) were measured in the sera and synovial fluids using enzyme linked immunosorbant assay. We found some variations in the counts of T cell subsets, the levels of cytokines and sICAM-1 adhesion molecule between the healthy controls and the patients with arthritis. High levels of IL-1beta, IL-10, IL-17 and TNF-alpha (in the serum and synovial fluid) were observed in arthritis compared to the healthy controls. In rheumatoid arthritis, a high serum level of sICAM-1 was found compared to its level in the synovial fluid. A high CD4(+)/CD8(+) T cell ratio was found in the blood of the patients with rheumatoid arthritis. In rheumatoid arthritis, the cytokine levels correlated positively with some clinicopathologic features. To conclude, the development of rheumatoid arthritis and osteoarthritis is associated with alteration of the levels of some cytokines. The assessment of these immunologic changes may have potential prognostic roles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392953     DOI: 10.1007/s12253-008-9016-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  50 in total

1.  Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells.

Authors:  R Pigott; L P Dillon; I H Hemingway; A J Gearing
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

2.  IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine?

Authors:  Pierre Miossec
Journal:  Joint Bone Spine       Date:  2004-03       Impact factor: 4.929

Review 3.  Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?

Authors:  G R Burmester; B Stuhlmüller; G Keyszer; R W Kinne
Journal:  Arthritis Rheum       Date:  1997-01

4.  Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.

Authors:  Fionula M Brennan; Amanda L Hayes; Cathleen J Ciesielski; Patricia Green; Brian M J Foxwell; Marc Feldmann
Journal:  Arthritis Rheum       Date:  2002-01

5.  Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.

Authors:  C M Verhoef; J A van Roon; M E Vianen; J W Bijlsma; F P Lafeber
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

6.  Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population.

Authors:  Z Khalkhali-Ellis; E A Seftor; D R Nieva; R E Seftor; H A Samaha; L Bultman; J E De Larco; A Ince; T L Moore; M J Hendrix
Journal:  J Rheumatol       Date:  1997-12       Impact factor: 4.666

7.  C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors.

Authors:  Z Khalkhali-Ellis; G A Bulla; L S Schlesinger; D A Kirschmann; T L Moore; M J Hendrix
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

8.  Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations.

Authors:  P Dolezalová; P Telekesová; D Nemcová; J Hoza
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

9.  Elevated interleukin-10 levels in patients with rheumatoid arthritis.

Authors:  J J Cush; J B Splawski; R Thomas; J E McFarlin; H Schulze-Koops; L S Davis; K Fujita; P E Lipsky
Journal:  Arthritis Rheum       Date:  1995-01

10.  Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis.

Authors:  J K Franz; S A Kolb; K M Hummel; F Lahrtz; M Neidhart; W K Aicher; T Pap; R E Gay; A Fontana; S Gay
Journal:  Eur J Immunol       Date:  1998-09       Impact factor: 5.532

View more
  39 in total

1.  Inflammatory response in patients with active and inactive osteoarthritis.

Authors:  Antoaneta Toncheva; Mimi Remichkova; Krassimira Ikonomova; Petya Dimitrova; Nina Ivanovska
Journal:  Rheumatol Int       Date:  2009-01-30       Impact factor: 2.631

2.  An orthologous non-MHC locus in rats and mice is linked to CD4+ and CD8+ T-cell proportion.

Authors:  D Franckaert; R Collin; J Dooley; R H Wallis; P Poussier; A Liston; E E Hillhouse; S Lesage
Journal:  Genes Immun       Date:  2017-05-25       Impact factor: 2.676

Review 3.  Leukocyte function in the aging immune system.

Authors:  Anjali Desai; Annabelle Grolleau-Julius; Raymond Yung
Journal:  J Leukoc Biol       Date:  2010-03-03       Impact factor: 4.962

4.  CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis.

Authors:  Amina Bensalem; Denis Mulleman; Gilles Thibault; Nicolas Azzopardi; Philippe Goupille; Gilles Paintaud; David Ternant
Journal:  Br J Clin Pharmacol       Date:  2019-11-22       Impact factor: 4.335

Review 5.  Immune Contributions to Osteoarthritis.

Authors:  Erika Barboza Prado Lopes; Adrian Filiberti; Syed Ali Husain; Mary Beth Humphrey
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

6.  Mitochondrial ROS activate interleukin-1β expression in allergic rhinitis.

Authors:  Qiping Shi; Zhiwei Lei; Gui Cheng; Dehai Li; Qian Wang; Simin Luo; Hengwen Yang; Haiying Jia
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

7.  Pain sensitivity and pain reactivity in osteoarthritis.

Authors:  Yvonne C Lee; Bing Lu; Joan M Bathon; Jennifer A Haythornthwaite; Michael T Smith; Gayle G Page; Robert R Edwards
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10-18       Impact factor: 4.794

8.  TNFα-mediated apoptosis in human osteoarthritic chondrocytes sensitized by PI3K-NF-κB inhibitor, not mTOR inhibitor.

Authors:  Deling Li; Zhihong Wu; Yuanhui Duan; Dongsheng Hao; Xinbo Zhang; Hui Luo; Baosheng Chen; Guixing Qiu
Journal:  Rheumatol Int       Date:  2011-04-09       Impact factor: 2.631

9.  Evaluation of lymphocyte levels in a random sample of 218 elderly individuals from São Paulo city.

Authors:  Daniela Teixeira; Ieda Maria Longo-Maugeri; Jair Licio Ferreira Santos; Yeda Aparecida Oliveira Duarte; Maria Lucia Lebrão; Valquiria Bueno
Journal:  Rev Bras Hematol Hemoter       Date:  2011

10.  Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.

Authors:  Aimée C Colbath; Steven W Dow; Leone S Hopkins; Jennifer N Phillips; C Wayne McIlwraith; Laurie R Goodrich
Journal:  Equine Vet J       Date:  2020-02-14       Impact factor: 2.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.